PATENT CLAIM ANALYSIS

Application Number: 15942001
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "157000"]

Abstract:
This invention relates to modified hydroxylases. The invention further relates to cells expressing such modified hydroxylases and methods of producing hydroxylated alkanes by contacting a suitable substrate with such cells.

Claim (Index 7):
The isolated or recombinant polypeptide of  claim 5 , wherein the polypeptide comprises at position 47 a cysteine (C), at position 78 a phenylalanine (F), at position 82 a serine (S), at position 94 an isoleucine (I), at position 142 a serine (S), at position 175 an isoleucine (I), at position 184 a valine (V), at position 205 a cysteine (C), at position 226 an arginine (R), at position 236 a glutamine (Q), at position 252 a glycine (G), at position 255 a serine (S), at position 290 a valine (V), at position 328 a phenylalanine (F), and at position 353 a valine (V).

Metadata:
- Claim Count in Document: 28.0
- Percentile: 90.0
- Lexical Diversity: 1.33333
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14788365', '11697404', '14270268', '15224900', '13659144']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6895054389475864
- 35 USC 102 Novelty (BERT): 0.6424492707935732
- Combined Prediction Score: 0.6847998221321852
- Mean Citation Score: 629.3445960000001
- Max Citation Score: 743.80457
- Similarity Product: 545.1796076942646

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test